Azithromycin and Gentamicin Therapy for the Treatment of Humans with Brucellosis
Authors:
- Javier SoleraJSJavier Solera
- for the Grupo de Estudio de Castilla la Mancha de Enfermedades Infecciosas GroupFGfor the Grupo de Estudio de Castilla la Mancha de Enfermedades Infecciosas Group
Open Access
- 1 February 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (3) , 506-509
Abstract
Ten patients with brucellosis were treated with azithromycin and gentamicin to assess the treatment's safety and efficacy. Seven patients had an excellent therapeutic response at the end of therapy; however, relapse was noted in 3. When relapse was considered in combination with an initial lack of efficacy, 5 patients (50%; 95% confidence interval, 18.7%–81.3%) did not respond to therapy; these results do not favor the use of azithromycin to treat brucellosis in humans.Keywords
This publication has 14 references indexed in Scilit:
- Recognition and Optimum Treatment of BrucellosisDrugs, 1997
- Treatment of Human Brucellosis with Netilmicin and DoxycyclineClinical Infectious Diseases, 1996
- Comparative activity of azithromycin and doxycycline against Brucella spp. infection in miceJournal of Antimicrobial Chemotherapy, 1995
- Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades InfecciosasAntimicrobial Agents and Chemotherapy, 1995
- Antibacterial Activity of Azithromycin against Brucella melitensisChemotherapy, 1995
- In vitro activities of new macrolides and rifapentine against Brucella sppAntimicrobial Agents and Chemotherapy, 1993
- In vitro activity of azithromycin and tetracycline against 358 clinical isolates ofBrucella melitensisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Phagocyte uptake and transport of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Modern Chemotherapy for Brucellosis in HumansClinical Infectious Diseases, 1990
- In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infectionAntimicrobial Agents and Chemotherapy, 1989